Therapeutic Asset Ratings
766 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
225ac-etn029
Prostate Neuroendocrine Neoplasm
Novartis Pharmaceuticals
P1
CC
(43)
225ac-psma-trillium
Castration-Resistant Prostate Carcinoma
Bayer
P1
CC
(43)
225ac-psma-trillium
Prostate Carcinoma
Bayer
P1
CC
(43)
225ac-psma-xt
Castration-Resistant Prostate Carcinoma
Xiaorong Sun
P1
CC
(43)
[225]-fpi-2059
Prostate Neuroendocrine Neoplasm
3B Pharmaceuticals GmbH
P1
CC
(43)
[225]-fpi-2059
NTSR1 Expressing Solid Tumours
3B Pharmaceuticals GmbH
P1
CC
(43)
4.7 microci 225ac-mti-201
Metastatic Neoplasm
Modulation Therapeutics, Inc.
P1
CC
(43)
[68ga]ga-dwj155
Gastroesophageal Cancer
Novartis Pharmaceuticals
P1
CC
(43)
68ga-r11228
Hormone Receptor-Positive Breast Cancer
Radionetics Oncology
P1
CC
(43)
89-zr-dfo-star polyethylene glycol
Soft Tissue Neoplasm
Robert Flavell, MD, PhD
P1
CC
(43)
998 microci of 225ac-mti-201
Metastatic Neoplasm
Modulation Therapeutics, Inc.
P1
CC
(43)
99mtc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
Primary Systemic Amyloidosis
University of Tennessee Graduate School of Medicine
P1
CC
(43)
Copper Cu 64-Dota-A2Dm
Malignant Pancreatic Neoplasm
City of Hope Medical Center
P1
CC
(43)
Fluciclovine
Prostate Neuroendocrine Neoplasm
Brigham and Women's Hospital
P1
CC
(43)
Gallium-68 Labelled Fap-2286
Solid Tumors, Adult
Thomas Hope
P1
CC
(43)
Indium In 111-Dota-Daratumumab
Plasma Cell Myeloma
City of Hope Medical Center
P1
CC
(43)
Jnj-69086420
Adenocarcinoma
Janssen Research & Development, LLC
P1
CC
(43)
lu-177 labeled 6a10-fab-fragments
Glioblastoma
University Hospital Muenster
P1
CC
(43)
Lutetium [177Lu] Bl-Arc001
Digestive System Neoplasm
Sichuan Baili Pharmaceutical Co., Ltd.
P1
CC
(43)
Lutetium Lu 177 Psma-10.1
Prostate Carcinoma
Emory University
P1
CC
(43)
Mdn-001
Hepatocellular Carcinoma
Suzhou Mednovo Yi Medical Technology Co., Ltd.
P1
CC
(43)
Psma-Hbed-Cc
Metastatic Neuroendocrine Prostate Cancer
Novartis Pharmaceuticals
P1
CC
(43)
ryz101
Small Cell Lung Carcinoma
RayzeBio, Inc.
P1
CC
(43)
Yttrium-90
Metastatic Neoplasm
M.D. Anderson Cancer Center
P1
CC
(43)
Yttrium-90
Liver Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Showing 276 to 300 of 766 assets
Previous
Page 12 of 31
Next
